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Abstract
Background: Dental plaque formed on tooth surfaces is a complex ecosystem composed of diverse oral bacteria
and salivary components. Accumulation of dental plaque is a risk factor for dental caries and periodontal diseases.
L-arginine has been reported to decrease the risk for dental caries by elevating plaque pH through the activity of
arginine deiminase in oral bacteria. Here we evaluated the potential of L-arginine to remove established oral biofilms.
Methods: Biofilms were formed using human saliva mixed with Brain Heart Infusion broth supplemented with 1 %
sucrose in multi-well plates or on plastic discs. After washing the biofilms with saline, citrate (10 mM, pH3.5), or L-
arginine (0.5 M, pH3.5), the retained biofilms were analyzed by crystal violet staining, scanning electron microscopy,
and Illumina-based 16S rDNA sequencing.
Results: Washing with acidic L-arginine detached oral biofilms more efficiently than saline and significantly reduced
biofilm mass retained in multi-well plates or on plastic discs. Illumina-based microbiota analysis showed that citrate
(pH3.5) preferentially washed out Streptococcus from mature oral biofilm, whereas acidic L-arginine prepared with
10 mM citrate buffer (pH3.5) non-specifically removed microbial components of the oral biofilm.
Conclusions: Acidic L-arginine prepared with citrate buffer (pH3.5) effectively destabilized and removed mature oral
biofilms. The acidic L-arginine solution described here could be used as an additive that enhances the efficacy of
mouth rinses used in oral hygiene.
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Background
There is accumulating evidence that deterioration of oral
hygiene is associated with periodontal disease [1] as well
as increased risk for cardiovascular disease [2, 3], meta-
bolic syndrome [4, 5], and pre-term birth [6]. Oral hy-
giene care is also recognized as a critical measure that
reduces the risks for health care-associated pneumonia
(HCAP). Oral biofilms can act as reservoirs for
pneumonia-related bacteria, as suggested by the similar-
ity between oral microbiota and clinical HCAP samples
[7–9]. Many clinical trials that investigated the effective-
ness of oral hygiene care on prophylaxis for HCAP, in-
cluding pneumonia arising from mechanical ventilation,
have been reported. These trials found: (i) mechanical
and chemical oral hygiene measures reduced the rate of
respiratory pathogen colonization in oral microbiota
[10, 11]; (ii) oral hygiene care with either chlorhexidine
mouthwash or gel was associated with a 40 % reduction
in ventilator-associated pneumonia in critically ill
adults [12]; and (iii) mechanical oral cleaning signifi-
cantly reduced the risk for fatal pneumonia [13].
Oral cavities contain diverse microbiota that num-
bers nearly 700 species [14]. This ecosystem includes
biofilm-forming bacteria such as Streptococcus mutans,
Fusobacterium nucleatum, Porphyromonas gingivalis, and
Aggregatibacter actinomycetemcomitans. Although the
microbiota varies among individuals, within a given indi-
vidual the oral microbiome is relatively stable [15]. How-
ever, the oral microbial composition can change rapidly
under compromised conditions that can occur during
hospitalizations [16]. Therefore, oral hygiene care for
critically ill patients is especially important to prevent
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colonization of multi-drug resistant bacteria or over-
growth of respiratory pathogens. Inadequate oral hygiene
may result in the formation of mature dental plaque on
tooth surfaces or oral epithelial cells, and this plaque can
be resistant to cleansing by rinsing with water or even
with manual tooth brushing, which highlights the need for
effective strategies that suppress oral biofilm formation.
Various trials to test the ability of herbal extracts [17], dis-
infectants [18, 19], inhibitors of polysaccharide production
[20, 21], and rare sugars [22] to reduce formation of oral
biofilms have been conducted.
Recently, alkali-generating agents such as L-arginine
and urea were predicted to inhibit the growth of acido-
genic or aciduric bacteria by raising the pH of the oral
environment [23]. Metabolism of L-arginine and urea by
arginine deiminase and urease, respectively, produces
ammonia. Many oral bacteria possess an arginine deimi-
nase system, which metabolizes L-arginine to produce
ornithine and ammonia that increases the pH of oral bio-
films. Clinical trials investigating L-arginine-containing
dentifrices or mouth rinses showed a protective effect
against development of dental caries in young subjects
[24, 25]. In addition, L-arginine and fluoride synergis-
tically suppressed S. mutans growth and biofilm for-
mation [26].
L-arginine is a basic amino acid that contains a guan-
idine group. Like guanidine hydrochloride, L-arginine
can increase protein solubility and suppress protein
aggregation [27]. Although the precise mechanism for L-
arginine-mediated inhibition of protein-protein interac-
tions remains unclear, L-arginine can change the surface
tensions of proteins by interacting with proteins or the
water surrounding them without the tight attachment
seen with other agents such as guanidine hydrochloride
[28]. Because this mild interaction preserves protein
functions, L-arginine has been used for solubilization of
exogenously expressed proteins or antibodies for
pharmaceutical use. In addition, L-arginine was recently
reported to diminish the infectivity of envelope viruses
such as herpes simplex virus and influenza virus, prob-
ably due to compromised function of proteins in the
envelope [29].
Oral biofilm is a complex ecosystem that is composed
of diverse bacteria, insoluble glucan, and salivary glyco-
proteins. Removing this solid biological plaque from
tooth surfaces by simple water rinsing or even with
mechanical brushing can be difficult. Residual plaque
also serves as a base for further biofilm formation.
Because L-arginine is expected to inhibit oral biofilm
formation and also destabilize complex aggregates in
dental plaque, inclusion of this amino acid in a mouth
rinse could facilitate oral biofilm removal. In this study,
we evaluated the potential of L-arginine as a cleanser to
remove already established oral biofilms.
Methods
Killing assay for Streptococcus mutans
Glycerol stocks of S. mutans GS5 were streaked on Brain
Heart Infusion (BHI) agar plates that were then incu-
bated anaerobically at 37 °C for 48 h. Anaerobic culture
was performed using an AnaeroPack system (Mitsubishi
Gas Co., Ltd.). Several S. mutans GS5 colonies were in-
oculated into BHI broth and cultivated at 37 °C for 48 h.
The cultures were centrifuged at 15,000 rpm for 5 min
and resuspended in saline. Bacterial suspensions (0.1 ml)
were added to 0.9 ml of saline, 10 mM citrate (pH3.5),
or 0.5 M L-arginine in 10 mM citrate (pH3.5). After in-
cubating for 5 min at 37 °C, serial 10-fold dilutions with
phosphate-buffered saline (PBS, pH7.4) were prepared,
and 0.1 ml of the appropriate dilution was spread onto
BHI agar plates. After a 72 h anaerobic incubation at
37 °C, the number of colonies was counted and com-
pared with the number in the saline treatment.
Biofilm inhibition assay
To assess the inhibitory effect on S. mutans GS5 biofilm
formation, 0.1 ml saline, 10 mM citrate (pH3.5), or
0.5 M L-arginine pH3.5–7.0 (adjusted by 10 mM citrate
buffer) were mixed with an equal volume of the bacterial
suspension (1 % v/v of 48 h culture) in 2 x BHI containing
2 % sucrose. The mixtures were added to 96-well plates
and incubated anaerobically at 37 °C. After a 24 h cultiva-
tion, the biofilms formed on the well bottoms were quan-
tified by crystal violet staining as described below.
Collection of human salivary samples
After written informed consent was obtained from nine
healthy volunteers (21–27 years old, male), they were
requested to collect saliva excreted while chewing wax
gum for 5 min. Exclusion criteria were younger than
20 years old or having received antibiotic treatment
within the previous 4 weeks.
Cleansing effect of L-arginine on oral biofilm formed on
plastic discs
Human oral biofilms were formed on 13.5-mm sterile
plastic discs (Sensi-Disc, Sumitomo Bakelite, Co., Ltd.,
Tokyo), set in 24-well culture dishes. The discs were in-
cubated in 0.5 ml BHI containing 1 % sucrose and 20 %
human saliva collected from three healthy volunteers
(#1-#3). After a 72 h anaerobic cultivation, the discs
were removed and washed once with saline. The bio-
films on the discs were further washed with 0.5 ml of
10 mM citrate (pH3.5), 0.5 M each of L-arginine, L-
alanine, L-glycine or L-lysine (all adjusted the pH at 3.5
by 10 mM citrate) by shaking for 30 min at 37 °C. The
discs were then washed again with 0.5 ml PBS (pH7.4),
stained with 0.5 ml 0.01 % crystal violet for 20 min at
room temperature. The discs were then washed four
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times with 1.0 ml saline and air-dried. After taking
photograph, the remaining dye was eluted with 0.5 ml
33 % acetic acid by shaking for 30 min at room
temperature. The absorbance of the eluents at 550 nm
was then measured.
Cleansing assay on human salivary biofilm using
microwells
Human saliva collected from four healthy volunteers
(#4-#7) were added to BHI containing 1 % sucrose at 20 %
(v/v). Modified human oral biofilms were also prepared by
adding 48 h S. mutans GS5 cultures (1 % final volume) to
simulate cariogenic biofilm. Each mixture (0.1 ml) was
then added to 96-well plates and incubated anaerobically
at 37 °C. After 72 h, the cultures were removed, and the
biofilm formed on the bottom of the plates was washed
once with 0.2 ml saline. Each well was then washed with
0.1 ml saline (control), 10 mM citrate (pH3.5, solvent for
L-arginine in this study), or 0.5 M L-arginine (pH3.5) by
shaking for 30 min at 37 °C. The test reagents were dec-
anted and each well was washed three times with 0.2 ml
saline. The remaining biofilm was stained with 0.1 ml
0.01 % crystal violet for 20 min at room temperature.
After staining, the wells were washed four times with
0.2 ml saline, and the remaining dye was eluted with
0.2 ml 33 % acetic acid by shaking for 30 min at room
temperature. The absorbance of the eluents at 550 nm
was then measured. Six wells were used for each sample
in a single assay. Assays were repeated three times
independently.
Scanning electron microscopy
Human oral biofilms were formed on 13.5-mm sterile
plastic discs using the samples from #4 to #7. The discs
were incubated in 0.5 ml BHI containing 1 % sucrose
and 20 % human saliva. After a 72 h anaerobic cultiva-
tion, the discs were removed and washed once with sa-
line. The biofilms on the discs were further washed with
0.5 ml saline, 10 mM citrate (pH3.5), or 0.5 M L-argin-
ine (pH3.5) by shaking for 30 min at 37 °C. The discs
were then washed again with 0.5 ml PBS (pH7.4), and
the biofilms on the discs were fixed with 2 % glutaralde-
hyde in 0.1 M cacodylate buffer (pH7.2). After fixation,
the biofilms were dehydrated in a graded ethanol series
and dried in a Hitachi PCP-2 critical point drying appar-
atus. The discs were coated with platinum/palladium in
a Hitachi E-102 sputter coater and examined with a
JEOL JCM-6000 scanning electron microscope. The bio-
film area retained after washing with each test reagent
was measured using the color auto-selection tool in
Photoshop CS6. The pixel value ratios of the biofilm
area to total observation area were calculated from five
randomly selected fields at 100x magnification.
Microbial composition analysis by 16S rDNA sequencing
The salivary microbiome of the six healthy volunteers
(#4-#9) was characterized by Illumina Miseq 16S rDNA
sequencing analysis of DNA extracted from 3 ml saliva.
To identify the microbial groups that were sensitive to
citrate or L-arginine rinsing, human saliva-derived bio-
films formed on 13.5-mm plastic discs were washed with
the test reagents described above. The test reagents were
then recovered, and the bacteria from the washings were
collected by centrifugation (washed-out fraction). The
discs were washed three times with 0.5 ml saline, cut
into pieces with sterile scissors, and then transferred to
0.5 ml saline for sonication with a Bioruptor (Cosmobio,
3 x 1 min with 1-min interval, output setting H). The
detached biofilms were collected by centrifugation (sus-
tained fraction). DNA from both fractions was also puri-
fied and the microbial composition determined by 16S
rDNA sequencing analysis.
DNA extraction was performed according to the method
reported by Morita et al. [30]. Sequencing libraries were
prepared by amplifying the V3-V4 region of the 16S rDNA
using the primers described by Klindworth et al. [31]. After
initial amplification, a second PCR was performed to attach
Illumina adaptors as well as barcodes that allowed for mul-
tiplexing. Amplifications were performed in 25 μl reactions
containing 2.5 μl diluted template, 12.5 μl 2x KAPA HiFi
HotStart Ready Mix and 2.5 μl of each primer. Thermal
cycling consisted of an initial denaturation step (3 min
at 95 °C), followed by 25 cycles of denaturation (30 s at
95 °C), annealing (30 s at 55 °C) and 30 s extension at
72 °C. The final extension step consisted of 5 min at 72 °C.
Amplicons were purified using AMPure XP beads (Beck-
man Coulter). Sequencing was performed on the Illumina
MiSeq platform (MiSeq Reagent Kit ver. 3, 600 cycles) ac-
cording to the manufacturer’s specifications to generate
paired-end reads of 300 bases in each direction. A total of
10,381,210 2 x 300 base pair reads with an average of
432,550 reads per sample was obtained. Primer sequences
were trimmed, and the paired-end reads merged using
Fastq-join [32] with default parameters and processed with
the QIIME 1.8.0 pipeline [33]. After a chimera check by
Usearch, 20,000 Illumina reads per sample (average quality
score above 20) were randomly selected for further analysis.
Using the UCLUST [34] algorithm built into the QIIME
pipeline, sequences were clustered at > 97 % identity against
the Greengenes reference database, producing 635 oper-
ational taxonomic units (OTUs). Using the QIIME pipeline,
unweighted UniFrac distances were produced and used to
investigate beta diversity by plotting PCA coordinates.
Nucleotide seqeunce
Sequence data have been deposited in DDBJ database
(accession number: DRA004109, PRJDB4298, SAMD
00042426-SAMD00042441).
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Statistics
Statistical analysis of the data was performed with Stat-
Flex ver. 6.0 (Artech Co., Ltd., Tokyo) using analysis of
variance (ANOVA) to compare the means of all groups
and followed by Tukey’s test to compare the means
of each of the two groups. Data were considered to
be significantly different if the 2-tailed p value was
less than 0.05.
Ethics consent and permissions
Human saliva were collected from nine healthy volun-
teers after written informed consent was obtained.
Ethical approval was obtained from the Research Ethics
Committee of the Faculty of Medicine, Kagawa Univer-
sity (reference number, 27-074).
Consent to publish
The authors obtained consent from all of the part-
icipants to publish the analysis data under linkable
anonymizing.
Results
Inhibitory effect of L-arginine on S. mutans GS5 biofilm
formation
Biofilm assays were performed to determine the effect of
L-arginine on S. mutans GS5 biofilm formation under
pH conditions ranging from acidic to neutral (pH3.5–7.0).
Firstly, S. mutans GS5 culture was added to 2 x BHI
containing 2 % sucrose at 2 % (v/v). The bacterial sus-
pension (0.1 ml) was then mixed with saline, 10 mM
citrate (pH3.5) or 0.5 M each of L-arginine solution ad-
justed its pH (3.5–7.0) and applied to the microwells.
After 24-h anaerobic cultivation, S. mutans biofilm was
quantified by crystal violet staining. As shown in Fig. 1,
L-arginine solutions (final concentration, 0.25 M) that
were adjusted to pH3.5 significantly inhibited S. mutans
biofilm after 24 h of cultivation when compared with
saline or buffer control (5 mM citrate, pH3.5). The
effect of L-arginine was pH-dependent, wherein only L-
arginine solutions adjusted to pH3.5 significantly inhib-
ited biofilm formation. Furthermore, this inhibition was
unlikely to be due to a bactericidal effect, because
10 mM citrate buffer (pH3.5) and L-arginine adjusted
to pH3.5 reduced S. mutans GS5 number by only 0.61 ±
0.30 and 0.49 ± 0.22 log10 CFU/ml during a 5-min contact,
respectively, and the optical density of the S. mutans cul-
ture after 24 h incubation was not different among the
samples with and without 0.25 M L-arginine solution
(pH3.5). These results suggest that acidic L-arginine
destabilized biofilm structure and/or reduced insoluble
glucan production of S. mutans. Based on these results,
acidic L-arginine solutions adjusted to pH3.5 were used
for subsequent analyses.
Cleansing effect of L-amino acid solution on oral biofilm
Saliva-derived biofilm was prepared on plastic discs
using the saliva samples from healthy adults (#1, #2, and
#3). After the biofilm was washed with 10 mM citrate
(pH3.5), 0.5 M each of L-arginine, L-glycine, L-lysine or
L-alanine solutions, which were adjusted the pH to 3.5.
As shown in Fig. 2a, the crystal violet stains on the discs
washed with L-arginine were less than those washed
with citrate buffer or the other three L-amino acids
tested. The crystal violet dyes were eluted with acetic
acid, and the absorbance at 550 nm of the elution was
measured to quantify the retaining biofilms on the discs.
As shown in Fig. 2b, L-arginine reduced human salivary
biofilm more effectively than other L-amino acids al-
though significant difference was not observed.
Fig. 1 pH-dependent inhibition of S. mutans GS5 biofilm formation by L-arginine. Diluted S. mutans GS5 cultures and test reagents were mixed at 1:1.
After the mixtures were cultured anaerobically at 37 °C for 24 h, S. mutans biofilms that had formed at the bottom of the microwells were quantified
by crystal violet staining. Saline (S), 10 mM citrate pH3.5 (CA3.5) or 0.5 M L-arginine solution adjusted with 10 mM citrate buffer to a pH between 3.5
and 7.0 (indicated as LA3.5-LA7.0) were used as test reagents. The data are expressed as means ± standard deviation. * Significantly different from saline
(p < 0.05), ** Significantly different from 10 mM citrate (pH3.5) (p < 0.05)
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Destabilizing effect of acidic L-arginine on oral biofilms
To further evaluate the destabilization effect of acidic L-
arginine (pH3.5) on human oral biofilm, the saliva sam-
ples were collected from four healthy volunteers (#4, #5,
#6, and #7). Illumina-based 16S rDNA sequencing
analysis showed that these samples contained the micro-
biome consistent with several previous reports on hu-
man saliva [35, 36]: Streptococcus (most predominant,
23.2–44.5 % abundance rate in this study), Prevotella,
Neisseria, Veillonella, Rothia, Fusobacterium, Gemella,
Porphyromonas, Haemophilus, Granulicatella, and Acti-
nomyces were commonly detected as abundant genera
(see Additional files 1, 2 and 3 for a detailed summary of
abundance rates).
The saliva samples were added to microwells contain-
ing BHI and 1 % sucrose (20 % v/v), and biofilms were
formed following anaerobic incubation for 72 h. Interest-
ingly, the biofilm characteristics differed among samples,
wherein the salivary biofilms from two individuals (#5
and #6) tightly attached to the wells (defined as solid
biofilms), while the other two (#4 and #7) were easily de-
tached by washing with saline (defined as fragile
biofilms) (Fig. 3a). Washing the wells with acidic L-
arginine detached more biofilms from #5 and #6 than
did saline (p < 0.05), whereas 10 mM citrate (pH3.5)
alone was similar to that of saline.
To simulate the cariogenic biofilm, S. mutans GS5 was
added to 1 % of the final well volume. The addition of S.
mutans GS5 changed the biofilm structure and increased
the attachment to the microwells, especially in saliva
samples that formed fragile biofilms (Fig. 3 and
Additional file 4). Similar to the biofilm cleansing assay
without S. mutans GS5, acidic L-arginine significantly
detached more biofilm derived from the saliva of #5 and
#6 (Fig. 3a). In contrast, biofilm containing strain GS5
became sensitive to washing with 10 mM citrate (pH3.5)
(Fig. 3b). Meanwhile, acidic L-arginine (pH3.5) and
10 mM citrate (pH3.5) also tended to reduce biofilms
formed by fragile biofilm-forming saliva samples (#4 and
#6) and S. mutans GS5, but no significant differences
were observed.
Biofilm structure after washing with acidic L-arginine
To further compare the human saliva (#4 to #7)-derived
biofilm after washing with saline, citrate (pH3.5), or
acidic L-arginine (pH3.5), scanning electron microscopy
(SEM) was performed. Biofilm was prepared on a plastic
disc using each of the saliva samples and washed with
the three test solutions (saline, 10 mM citrate pH3.5, or
0.5 M L-arginine pH3.5). The retaining biofilm area after
the washing was quantified at five randomly selected
SEM fields by Photoshop CS6 software. As shown in
Fig. 4, biofilm mass was reduced to the greatest degree
by acidic L-arginine (pH3.5). For samples washed with
saline and 10 mM citrate (pH3.5), thick, mat-like ob-
jects were retained after washing, whereas acidic L-
arginine removed the majority of these structures
(Additional file 5).
Oral bacterial groups susceptible to rinsing with acidic
L-arginine
Illumina-based 16S rDNA sequencing analysis was per-
formed to identify the bacterial groups that were sensi-
tive to rinsing with acidic L-arginine. We tested salivary
biofilm from samples #4 and #5 to represent solid and
fragile biofilms, respectively. Salivary biofilms were pre-
pared on plastic disc and washed with saline, 10 mM cit-
rate (pH3.5) or 0.5 M L-arginine (pH3.5) for 30 min.
The detached biofilms in the test solutions were col-
lected by centrifugation (washed-out fraction). The
retaining biofilms on the discs were detached by sonic-
ation and collected by centrifugation (retaining fraction).
The DNAs were purified from both factions. As shown
in Fig. 5, Streptococcus and Lactobacillus shared 86.8–
98.3 % of biofilm populations in both retained and
washed-out fractions. Solid biofilm (#5) contained more
Fig. 2 Cleansing effect of L-arginine on the salivary biofilm formed on
plastic discs. a Crystal violet staining of the biofilm retaining on the discs
after washing. The biofilm formed on the plastic disc was washed for
30 min with 10 mM citrate buffer (pH3.5; Cit), 0.5 M each of L-arginine
(Arg), L-glycine (Gly), L-lysine (Lys) or L-alanine (Ala), which were adjusted
the pH to 3.5 with 10 mM citrate buffer. b Quantification of the salivary
biofilm retaining on the discs. The crystal violet was eluted from the discs
shown in panel A with acetic acid and their absorbance at 550 nm was
measured. Relative values to citrate sample are shown
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Lactobacillus than fragile biofilm (#4). Interestingly, the
Streptococcus proportion in the washed-out fraction with
citrate buffer (10 mM, pH3.5) was higher than in those
with saline or 0.5 M L-arginine (pH3.5). On the other
hand, Lactobacillus tended to retain on the discs after
washing with citrate (pH3.5). These results indicated that
citrate (pH3.5) preferentially washed out Streptococcus
from both biofilm types. On the other hand, the microbial
profile of the wash fractions treated with acidic L-arginine
was similar to that seen for saline, indicating that acidic
L-arginine (pH3.5) non-specifically detached bacteria from
biofilms formed on plastic discs.
Discussion
Arginine deiminase in oral bacteria metabolizes L-
arginine that in turn raises the pH of the oral envir-
onment, which may suppress the formation of dental
caries. Thus, L-arginine has been explored as a potential
supplement to oral hygiene care [37]. In addition, high
concentrations of L-arginine (5.0–10.0 %) have been re-
ported to inhibit biofilm formation of cariogenic S.
mutans [26]. In this study, we explored the cleansing ef-
fect of L-arginine on oral biofilms to demonstrate the
benefits of this basic amino acid for oral hygiene care. L-
arginine inhibition of S. mutans biofilm formation was
indeed pH-dependent (Fig. 1), because among the range
of tested pH values (3.5–7.0), significant reductions in
biofilm formation were only observed at pH3.5. There-
fore, we tested relatively high concentrations (0.5 M) of
acidic L-arginine (pH3.5) in this study, and showed the
effectiveness of this solution in removing already estab-
lished oral biofilms. Because L-arginine enhances protein
solubility by affecting protein-protein interactions and
this effect is evident at acidic conditions [38, 39], the
cleansing effect on oral biofilms by acidic L-arginine that
was observed here is likely derived from a destabilization
of bacterial aggregation.
During the course of this study, Kolderman et al. re-
ported the destabilizing effect of L-arginine on biofilms
formed by saliva pooled from six healthy volunteers
[40]. This study reported that neutral pH L-arginine
Fig. 4 Quantification of sustained oral biofilm after cleansing. Oral
biofilms were formed on plastic discs by anaerobic cultivation in BHI
broth containing sucrose (1 %) and human saliva (10 %). After a 72 h
cultivation at 37 °C, the discs were washed with 1 ml PBS (pH7.4). The
discs were further washed with 1 ml saline, 10 mM citrate (pH3.5) or
0.5 M L-arginine (pH3.5) for 30 min before fixing with 2 % glutaraldehyde
in 0.2 M cacodylate buffer for scanning electron microscopy. Biofilm
areas were measured using a color-based auto-selection tool in
Photoshop CS6, and the ratios relative to the total observation field were
calculated. At least five randomly selected fields were examined. Data are
expressed as mean ± standard deviation, and the statistical analysis was
performed by ANOVA followed by Tukey’s test. The p-values less than
0.05 were considered to be significant
Fig. 3 Destabilization of oral biofilms by acidic L-arginine. Cleansing effect of saline, 10 mM citrate (pH3.5) or L-arginine in 10 mM citrate (pH3.5) on
established biofilms using human saliva alone (a) or human saliva mixed with S. mutans GS5 (1 % v/v) (b) was examined. The human saliva-derived
biofilms were prepared in microwell. After washing with the test reagents, the sustained biofilms were stained with crystal violet. The numbers indicate
the IDs of volunteers. Saline, 10 mM citrate (pH3.5) and acidic L-arginine (pH3.5) are indicated by blue, red, and green columns, respectively. Data are
expressed as mean ± standard deviation, and the statistical analysis was performed by ANOVA followed by Tukey’s test. The p-values less than 0.05
were considered to be significant
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(0.1–0.5 M) effectively destabilized oral biofilm. Herein,
we showed that acidic pH L-arginine not only destabi-
lized human oral biofilm but also inhibited biofilm for-
mation by S. mutans, although it is difficult to compare
the results in both studies due to differences in the bio-
film assay system used: the Kolderman et al. study used
filtered, cell-free saliva as a nutrient, whereas here we
used BHI containing 1 % sucrose as the supporting
medium for biofilm formation. Sucrose is a cariogenic
sugar that enhances the volume and solidity of oral bio-
film. The effect of sucrose on in vitro oral biofilm for-
mation was clearly observed in this study, wherein
added sucrose apparently altered the biofilm mass and
its composition with a marked increase in the number
of rod-shaped bacteria (Additional file 4). Considering
that Streptococcus and Lactobacillus were the predom-
inant components of the oral biofilms tested in this
study (Fig. 5), these rod-shaped bacteria were likely lac-
tobaclli. Such solid-biofilms formed in rich media may
be difficult to remove by neutral L-arginine, and acidic
conditions may facilitate destabilization of the aggre-
gates by L-arginine. In fact, Ikeda et al. revealed that
the antiviral effect of 0.7 M L-arginine on influenza
virus type A was most evident when the pH was below
pH5.0 [41].
We selected citrate buffer to adjust the pH of the L-
arginine solution because this acid has chelating activity.
The inhibitory effect of chelating agents on microbial
biofilm is well known, as evidenced by the frequent use
of EDTA or citrate in catheter lock solutions. Co-
aggregation of S. mutans and Lactobacillus has been re-
ported to be calcium dependent [42], while tight linkages
within S. mutans bacteria in Streptococcus biofilms
mediated by glucan-binding lectins are also dependent
on divalent cations [43]. Therefore, citrate would be ex-
pected to destabilize biofilms containing S. mutans
groups. This idea seemed to be supported by the finding
that citrate reduced salivary biofilms formed with S.
mutans GS5, whereas the acid was not effective against
biofilms that lacked S. mutans (Fig. 3). In addition,
Illumina-based analysis of wash fractions from oral bio-
films demonstrated that citrate washed out Streptococcus
to a greater degree than did saline or acidic L-arginine
(Fig. 5), indicating that a chelating effect of citrate
might be responsible for the removal of streptococci
from the biofilm.
The inhibitory and cleansing effects on oral biofilm
produced by acidic L-arginine were likely not bact-
ericidal, because acidic L-arginine (pH3.5) reduced S.
mutans GS5 by only 0.49 ± 0.22 log10 CFU during a
5 min contact. In addition, acidic L-arginine reduced the
numbers of salivary bacteria from the four healthy vol-
unteers by less than 1.0 log10 CFU/ml saliva (data not
shown). In their review, Marsh et al. emphasized the im-
portance of oral hygiene regimens that do not kill resi-
dent oral microflora, since intact oral microbiota can
play a crucial role in maintaining oral health through
colonization resistance or modification of oral epithelial
cell physiology [44]. The action of L-arginine meets this
viewpoint, because this amino acid appears to suppress
overgrowth of cariogenic bacteria without massive de-
struction of normal oral flora. Recently, L-arginine was
reported to show an antiviral effect against envelope vi-
ruses such as herpes simplex virus and influenza virus
[41, 45]. These findings, together with our results indi-
cate that mouth rinses supplemented with an acidic L-
Fig. 5 Comparative microbiota analysis of sustained and washed-out fractions with acidic L-arginine. Fragile (from #4) and solid biofilms (#5) were
formed on plastic discs, which were then washed with saline (S), 10 mM citrate buffer pH3.5 (CA), or acidic L-arginine (LA). The microbial composition
of the fraction remaining on the discs and the washed-out fraction were compared by Illumina-based 16S rDNA sequencing analysis
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arginine solution could inhibit dental plaque formation
and also protect against viral infection.
Although L-arginine and citrate are common and safe
food components, using acidic L-arginine solution (pH3.5)
in a mouthwash could promote enamel demineralization,
as sustained exposure to pH < 5.5 induces tooth
demineralization and increases the risk of caries [46].
However, since many fruit juices and soft drinks have
pH < 3.0 [46], the buffering action of saliva and arginine
deiminase systems in oral bacteria may restore oral pH
values to safe levels even after the use of a mouthwash
with acidic L-arginine (pH3.5). Nonetheless, this point
should be investigated in clinical studies to assess the
applicability of acidic L-arginine to oral hygiene care.
Notably, the saliva samples from the four healthy vol-
unteers included in this study formed biofilms with dif-
ferent characteristics, i.e., one was solid and the other
was fragile. We analyzed the salivary microbiomes of the
solid and fragile biofilms (three solid-biofilm formers,
SBF; three fragile-biofilm formers, FBF) by Illumina-
based 16S rDNA sequencing analysis. A principal coord-
inate analysis based on a UniFrac analysis at the OTU
level did not clearly separate the SBF and LBF samples
(Additional file 6), indicating that the different biofilm
characteristics might be derived from strain-level varia-
tions or differences in host factors. Because the salivary
pellicle is a basis for dental plaque formation, the cleans-
ing effect of acidic L-arginine might be influenced by
inter-individual variations in host factors such as salivary
glycoproteins and mucins, as well as the microbial
composition.
Conclusions
L-arginine has the potential to maintain oral health by
elevating dental plaque pH, inhibiting biofilm formation,
and destabilizing biofilm structure. In this study we
showed that acidic L-arginine (0.5 M) prepared in
10 mM citrate (pH3.5) efficiently removed oral biofilms
formed in the presence of rich nutrients. This effect was
likely achieved by the suppressive effect of L-arginine
toward aggregated organic matter and the chelating ef-
fect of citrate. The destabilization of the oral biofilm
structure by acidic L-arginine is expected to facilitate
washout of dental plaque during routine oral hygiene
care, although its effect may vary among individuals.
Therefore, future studies are needed to determine which
types of oral microbiota or host backgrounds determine
L-arginine sensitivity and to design oral hygiene care
regimens that use this amino acid. Development of
agents that include L-arginine may contribute to the re-
duction of dental caries, periodontal diseases, or HCAP.
For this purpose, the effect of L-arginine on oral micro-
biota should be carefully evaluated by clinical trials in
the future.
Additional files
Additional file 1. Comparison of OTU (97 % identity) richness derived from
rarefaction curves for saliva from healthy volunteers. By analyzing the 20,000
high quality sequences per sample, 300 to 400 operational taxonomy units
(OTUs, > 97 % identity) were detected in the samples. (TIF 645 kb)
Additional file 2. Microbial community structures in saliva from healthy
volunteers. Streptococcus and Prevotella represented more than 5 % of
the total salivary microbiota in all of the samples tested. See Additional
file 3 for detailed information on the relative abundance of each genus.
The salivary microbiota composition at the genus level was similar
among the samples. The Shannon-Weaver indices at the genus level of
the salivary microbiome from samples #4, #5, #6, and #7 were 2.92, 2.75,
2.64, and 2.29, respectively. (TIF 1230 kb)
Additional file 3. Summary of percent abundance of salivary microbiota
from healthy volunteers. (XLS 48 kb)
Additional file 4. Effect of 1 % sucrose and exogenously added Streptococcus
mutans on biofilm formation by salivary bacteria. Human saliva was cultured
anaerobically for 72 h at 37 °C in BHI only (a, d), or BHI containing 1 % sucrose
without (b, e) or with (c, f) 1 % volume of S. mutans (OD600 = 0.7). The biofilm
formed on plastic discs was examined by scanning electron microscopy at low
(500x, panels a, b, c) and high (3,000x, panels d, e, f) magnification. Sucrose
enhanced biofilm formation by human salivary bacteria. Culturing with sucrose
decreased filamentous-form bacteria (indicated by white arrowheads) but in-
creased the number of rod-shaped bacteria. Extracellular polysaccharide-like ob-
jects (white arrows) were observed when the sucrose solution was
supplemented with S. mutans. Bars in upper and lower panels indicate 50 μm
and 10 μm, respectively. (TIF 592 kb)
Additional file 5. Scanning electron microscopy of oral biofilms after
cleansing. Among the selected fields at 100x magnification, the most
biofilm-rich area in each sample is shown. Thick biofilm were observed
even after washing with saline or 10 mM citrate (pH3.5), whereas these
thick biofilms were removed after washing with acidic L-arginine (pH3.5).
Bars indicate 200 μm. (TIF 572 kb)
Additional file 6. PCoA plot describing unweighted UniFrac distance
between salivary samples. Pairwise distances between all samples are
projected onto a two dimensional space where the PCA axis describes
the highest degree of variation. Samples that are clustered closely together
are thus considered to share a larger proportion of the phylogenetic tree
compared to samples that have a larger separation. (TIF 47 kb)
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